8th January 2017
Home » New » A Placebo Controlled Trial Of Oral Fingolimod In Relapsing
A Placebo Controlled Trial Of Oral Fingolimod In Relapsing

A Placebo-Controlled Trial Of Oral Fingolimod In Relapsing - Original Article. A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis. Ludwig Kappos, M.D., Ernst-Wilhelm Radue, M.D., Paul O'Connor, M.D . Read more ...

Placebo-Controlled Phase 3 Study Of Oral BG-12 For - Original Article. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. Ralf Gold, M.D., Ludwig Kappos, M.D., Douglas L. Arnold, M.D., Amit . Read more ...

Ocrelizumab In Relapsing-remitting Multiple - The Lancet - Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Read more ...

Fingolimod - Wikipedia - Fingolimod (INN, trade name Gilenya, Novartis) is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). It has reduced the rate of relapses in . Read more ...

Gilenya (Fingolimod Capsules): Side Effects, Interactions - Learn about Gilenya (Fingolimod Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.. Read more ...

Gilenya - FDA Prescribing Information, Side Effects And Uses - Gilenya is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the . Read more ...

List Of Clinical Studies - Holy Name Medical Center - Holy Name Medical Center is a comprehensive, 361 bed acute care facility providing high-quality healthcare across a continuum that extends from prevention through . Read more ...

Laquinimod - Wikipedia - Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis (MS).. Read more ...

Multiple Sclerosis - Aetna - Treatment of acute exacerbations of multiple sclerosis (MS) when the acute relapse is characterized by functionally disabling symptoms with documented evidence of . Read more ...

Gilenya 0.5mg Hard Capsules - Summary Of Product - Each capsule contains 0.5 mg fingolimod (as hydrochloride). For the full list of excipients, see section 6.1.. Read more ...